Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study
- PMID: 16036343
- DOI: 10.1080/10715760500097906
Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study
Abstract
Since the higher redox potential of quinone molecules has been correlated with enhanced cellular deleterious effects, we studied the ability of the association of ascorbate with several quinones derivatives (having different redox potentials) to cause cell death in K562 human leukaemia cell line. The rationale is that the reduction of quinone by ascorbate should be dependent of the quinone half-redox potential thus determining if reactive oxygen species (ROS) are formed or not, leading ultimately to cell death or cell survival. Among different ROS that may be formed during redox cycling between ascorbate and the quinone, the use of different antioxidant compounds (mannitol, desferal, N-acetylcysteine, catalase and superoxide dismutase) led to support H2O2 as the main oxidizing agent. We observed that standard redox potentials, oxygen uptake, free ascorbyl radical formation and cell survival were linked. The oxidative stress induced by the mixture of ascorbate and the different quinones decreases cellular contents of ATP and GSH while caspase-3-like activity remains unchanged. Again, we observed that quinones having higher values of half-redox potential provoke a severe depletion of ATP and GSH when they were associated with ascorbate. Such a drop in ATP content may explain the lack of activation of caspase-3. In conclusion, our results indicate that the cytotoxicity of the association quinone/ascorbate on K562 cancer cells may be predicted on the basis of half-redox potentials of quinones.
Similar articles
-
Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice.Biochem Pharmacol. 2006 Sep 14;72(6):671-80. doi: 10.1016/j.bcp.2006.05.025. Epub 2006 Jul 7. Biochem Pharmacol. 2006. PMID: 16828058
-
Oxidative metabolism of combretastatin A-1 produces quinone intermediates with the potential to bind to nucleophiles and to enhance oxidative stress via free radicals.Chem Res Toxicol. 2007 Dec;20(12):1885-94. doi: 10.1021/tx7002195. Epub 2007 Oct 18. Chem Res Toxicol. 2007. PMID: 17941699
-
Intracellular ATP levels determine cell death fate of cancer cells exposed to both standard and redox chemotherapeutic agents.Biochem Pharmacol. 2011 Dec 1;82(11):1540-8. doi: 10.1016/j.bcp.2011.07.102. Epub 2011 Aug 9. Biochem Pharmacol. 2011. PMID: 21843513
-
Modulating factors of radical intensity and cytotoxic activity of ascorbate (review).Anticancer Res. 1997 Sep-Oct;17(5A):3513-20. Anticancer Res. 1997. PMID: 9413196 Review.
-
Reduction of protein radicals by GSH and ascorbate: potential biological significance.Amino Acids. 2010 Nov;39(5):1131-7. doi: 10.1007/s00726-010-0610-7. Epub 2010 Jun 9. Amino Acids. 2010. PMID: 20532951 Review.
Cited by
-
Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.Oxid Med Cell Longev. 2020 Nov 2;2020:6212935. doi: 10.1155/2020/6212935. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33204397 Free PMC article.
-
Synthesis and Evaluation of Folate-Conjugated Phenanthraquinones for Tumor-Targeted Oxidative Chemotherapy.Open J Med Chem. 2016 Mar;6(1):1-17. doi: 10.4236/ojmc.2016.61001. Epub 2016 Mar 11. Open J Med Chem. 2016. PMID: 27066312 Free PMC article.
-
Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy.Front Oncol. 2020 Feb 28;10:256. doi: 10.3389/fonc.2020.00256. eCollection 2020. Front Oncol. 2020. PMID: 32185131 Free PMC article. Review.
-
alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate.Br J Cancer. 2010 Apr 13;102(8):1224-34. doi: 10.1038/sj.bjc.6605617. Epub 2010 Mar 23. Br J Cancer. 2010. PMID: 20332775 Free PMC article.
-
DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.Free Radic Res. 2011 Mar;45(3):276-92. doi: 10.3109/10715762.2010.526766. Epub 2010 Nov 1. Free Radic Res. 2011. PMID: 21034357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials